What are the implications of drug-resistant Mycobacterium tuberculosis strains?
Drug-resistant strains of Mtb, such as MDR-TB and XDR-TB, pose a significant challenge due to limited treatment options and increased toxicity burden. Second-line drugs are often more toxic and less effective, requiring careful management to balance efficacy and safety. Toxicologists play a key role in developing new drugs with better safety profiles.
